DE3510129A1 - Lagerstabile, schnellzerfallende pharmazeutische wirkstoff-presslinge - Google Patents

Lagerstabile, schnellzerfallende pharmazeutische wirkstoff-presslinge

Info

Publication number
DE3510129A1
DE3510129A1 DE19853510129 DE3510129A DE3510129A1 DE 3510129 A1 DE3510129 A1 DE 3510129A1 DE 19853510129 DE19853510129 DE 19853510129 DE 3510129 A DE3510129 A DE 3510129A DE 3510129 A1 DE3510129 A1 DE 3510129A1
Authority
DE
Germany
Prior art keywords
water
pharmaceutical active
active ingredient
insoluble
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19853510129
Other languages
German (de)
English (en)
Inventor
Helmut Dr. Rheinfelden Kopf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of DE3510129A1 publication Critical patent/DE3510129A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19853510129 1984-03-23 1985-03-20 Lagerstabile, schnellzerfallende pharmazeutische wirkstoff-presslinge Withdrawn DE3510129A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1465/84A CH658188A5 (de) 1984-03-23 1984-03-23 Lagerstabile schnellzerfallende pharmazeutische presslinge.

Publications (1)

Publication Number Publication Date
DE3510129A1 true DE3510129A1 (de) 1985-10-03

Family

ID=4211107

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19853510129 Withdrawn DE3510129A1 (de) 1984-03-23 1985-03-20 Lagerstabile, schnellzerfallende pharmazeutische wirkstoff-presslinge

Country Status (26)

Country Link
US (1) US4666703A (forum.php)
JP (1) JPS60209518A (forum.php)
AT (1) AT394310B (forum.php)
AU (1) AU579355B2 (forum.php)
BE (1) BE901994A (forum.php)
CA (1) CA1239348A (forum.php)
CH (1) CH658188A5 (forum.php)
DE (1) DE3510129A1 (forum.php)
DK (1) DK162375C (forum.php)
ES (1) ES8702786A1 (forum.php)
FI (1) FI82187C (forum.php)
FR (1) FR2561524B1 (forum.php)
GB (1) GB2157170B (forum.php)
GR (1) GR850717B (forum.php)
HK (1) HK73090A (forum.php)
IE (1) IE57954B1 (forum.php)
IL (1) IL74666A (forum.php)
IT (1) IT1182723B (forum.php)
LU (1) LU85817A1 (forum.php)
NL (1) NL8500856A (forum.php)
NO (1) NO170125C (forum.php)
NZ (1) NZ211537A (forum.php)
PT (1) PT80147B (forum.php)
SE (1) SE8501370L (forum.php)
SG (1) SG46890G (forum.php)
ZA (1) ZA852160B (forum.php)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT350735B (de) * 1976-08-06 1979-06-11 Hoffmann La Roche Verfahren zur herstellung von neuen ribo- furanosyl-imidazolderivaten
CA1270765A (en) * 1985-02-19 1990-06-26 Charles Hsiao Controlled release potassium chloride
IE59066B1 (en) * 1985-02-19 1993-12-15 Key Pharma Controlled release potassium chloride
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
US4971791A (en) * 1985-08-26 1990-11-20 The Procter & Gamble Company Taste masking compositions
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
IT1197316B (it) * 1986-10-01 1988-11-30 Proter Spa Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
ES2039226T3 (es) * 1986-12-30 1993-09-16 American Cyanamid Company Procedimiento para preparar composiciones que contienen policarbofil.
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
US4789547A (en) * 1987-06-17 1988-12-06 Warner-Lambert Company Transdermal matrix system
US4904477A (en) * 1987-07-08 1990-02-27 American Home Products Corporation Spray dried ibuprofen compositions
US4927639A (en) * 1989-02-02 1990-05-22 Warner-Lambert Company Modified release gemfibrozil composition
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5122384A (en) * 1989-05-05 1992-06-16 Kv Pharmaceutical Company Oral once-per-day organic nitrate formulation which does not induce tolerance
DE3937455A1 (de) * 1989-11-10 1991-05-16 Nordmark Arzneimittel Gmbh Antacidatabletten
EP0462066A1 (en) * 1990-06-15 1991-12-18 Warner-Lambert Company Amorphous gemfibrozil
GB2257363B (en) * 1991-01-30 1994-09-28 Wellcome Found Water dispersible tablets containing acyclovir
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
ES2059260B1 (es) * 1992-10-06 1995-04-16 Espanola Prod Quimicos Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
DE4317172A1 (de) * 1993-05-22 1995-01-05 Rhone Poulenc Rorer Gmbh Geschmacksneutrale und schnellfreisetzende Buflomedil-Hydrochlorid-Arzneiform und Herstellungsverfahren desselben
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
US5674529A (en) * 1995-06-06 1997-10-07 Church & Dwight Co., Inc. Alkalinizing potassium salt controlled release preparations
PT861073E (pt) * 1995-11-14 2004-10-29 Abbott Gmbh & Co Kg Preparacoes de hormona da tiroide estabilizadas e metodos para prepara-las
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
DE69717810T2 (de) * 1996-04-26 2003-09-18 Shionogi & Co., Ltd. S1452-tabletten mit schneller freisetzung
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
HU221435B (en) * 1998-02-20 2002-10-28 Egyt Gyogyszervegyeszeti Gyar Pellet-based pharmaceutical composition of controlled release with high content of potassium-chloride, and process for it's production
FR2781793B1 (fr) * 1998-08-03 2001-07-20 Prographarm Lab Procede de fabrication de granules de gabapentine enrobes
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6500462B1 (en) * 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
US6399101B1 (en) 2000-03-30 2002-06-04 Mova Pharmaceutical Corp. Stable thyroid hormone preparations and method of making same
WO2001080826A2 (en) 2000-04-20 2001-11-01 Bristol-Myers Squibb Company Taste masking coating composition
US6932861B2 (en) * 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
BR0115585A (pt) 2000-11-28 2005-12-13 Fmc Corp Composições de revestimento de pronta liberação, endurecìvel, comestìvel, seca e, úmida, forma de dosagem sólida, e, método para revestir uma forma de dosagem sólida farmacêutica ou veterinária, confeito, semente, ração animal, fertilizante, comprimido de pesticida ou alimento
US20030032675A1 (en) * 2001-02-15 2003-02-13 Franz G. Andrew Manufacture of thyroid hormone tablets having consistent active moiety amounts
BR0207297A (pt) * 2001-02-15 2005-04-19 King Pharmaceuticals Inc Composição farmacêutica em forma sólida e método de preparar uma forma de dosagem sólida de um ingrediente farmaceuticamente ativo
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US20030224047A1 (en) * 2001-02-15 2003-12-04 Franz G. Andrew Levothyroxine compositions and methods
US20030180353A1 (en) * 2001-08-10 2003-09-25 Franz G. Andrew Stabilized pharmaceutical compositions
US20030190349A1 (en) * 2001-08-10 2003-10-09 Franz G. Andrew Methods of stabilizing pharmaceutical compositions
US20030198671A1 (en) * 2001-08-10 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique plasma AUC properties
US20030198667A1 (en) * 2001-08-10 2003-10-23 Franz Andrew G. Methods of producing dispersible pharmaceutical compositions
US20030195253A1 (en) * 2001-08-14 2003-10-16 Franz G. Andrew Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
US20030198672A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique triidothyronine plasma AUC properties
US20030199587A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique Cmax properties
US20030203967A1 (en) * 2001-08-14 2003-10-30 Franz G. Andrew Levothyroxine compositions having unique Tmax properties
US20030199586A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Unique levothyroxine aqueous materials
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US20030180356A1 (en) * 2001-10-29 2003-09-25 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Tmax properties
US6645526B2 (en) * 2001-11-13 2003-11-11 Mylan Pharmaceuticals, Inc. Storage stable thyroxine active drug formulations and methods for their production
US20030099699A1 (en) 2001-11-13 2003-05-29 Hanshew Dwight D. Storage stable thyroxine active drug formulations and methods for their production
CN1638803A (zh) * 2002-03-06 2005-07-13 协和发酵工业株式会社 口腔内速崩解性片剂
US20040029959A1 (en) * 2002-08-08 2004-02-12 John Devane Isosorbide mononitrate compositions and methods of their use
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
AU2007266574A1 (en) * 2006-06-01 2007-12-06 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
US20100092564A1 (en) * 2006-12-21 2010-04-15 Jae Han Park Composition of and Method for Preparing Orally Disintegrating Tablets
EP2101739A2 (en) * 2006-12-21 2009-09-23 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
CN101380474B (zh) * 2007-09-06 2012-07-25 北京大学 用于口服制剂的pH敏感性固体药物组合物及制备方法
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052076A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Schnellzerfallende Arzneimittel-Presslinge
EP0052705A1 (en) * 1980-11-24 1982-06-02 Joel E. Bernstein, M.D. Composition for treating acne vulgaris

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2200778B2 (de) * 1971-01-13 1974-04-18 Sandoz Ag, Basel (Schweiz) Verwendung von hochmolekularem, unlöslichem, quervernetztem Polyvinylpyrrolidon als Sprengmittel in festen Arzneiformen
BE785702A (fr) * 1971-07-14 1972-10-16 Roehm Gmbh Produits de revetement de formes medicamenteuses et leur utilisation
GB1540754A (en) * 1976-03-10 1979-02-14 Wellcome Found Tablet formulation
JPS5535031A (en) * 1978-09-04 1980-03-11 Shin Etsu Chem Co Ltd Enteric coating composition
CH642809B (fr) * 1980-11-07 Longines Montres Comp D Montre avec un mecanisme de quantieme perpetuel.
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
IT1168014B (it) * 1981-08-05 1987-05-20 Erba Farmitalia Forme farmaceutiche a cessione protratta

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052076A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Schnellzerfallende Arzneimittel-Presslinge
EP0052705A1 (en) * 1980-11-24 1982-06-02 Joel E. Bernstein, M.D. Composition for treating acne vulgaris

Also Published As

Publication number Publication date
FI851114L (fi) 1985-09-24
IL74666A (en) 1988-11-30
SE8501370L (sv) 1985-09-24
DK162375C (da) 1992-03-09
GR850717B (forum.php) 1985-07-19
BE901994A (fr) 1985-09-23
SE8501370D0 (sv) 1985-03-20
GB8506758D0 (en) 1985-04-17
IL74666A0 (en) 1985-06-30
DK162375B (da) 1991-10-21
JPH0574568B2 (forum.php) 1993-10-18
DK130685A (da) 1985-09-24
GB2157170A (en) 1985-10-23
AU579355B2 (en) 1988-11-24
NO170125C (no) 1992-09-16
LU85817A1 (de) 1985-12-12
CA1239348A (en) 1988-07-19
IT8547844A0 (it) 1985-03-21
ATA86885A (de) 1991-09-15
FR2561524B1 (fr) 1990-01-12
FI82187C (fi) 1991-02-11
ES8702786A1 (es) 1987-01-16
NO170125B (no) 1992-06-09
PT80147B (pt) 1987-10-20
ES541513A0 (es) 1987-01-16
IT8547844A1 (it) 1986-09-21
IT1182723B (it) 1987-10-05
JPS60209518A (ja) 1985-10-22
NL8500856A (nl) 1985-10-16
FI851114A0 (fi) 1985-03-20
AT394310B (de) 1992-03-10
ZA852160B (en) 1985-11-27
IE850744L (en) 1985-09-23
IE57954B1 (en) 1993-05-19
NZ211537A (en) 1988-03-30
US4666703A (en) 1987-05-19
CH658188A5 (de) 1986-10-31
NO851170L (no) 1985-09-24
DK130685D0 (da) 1985-03-22
PT80147A (en) 1985-04-01
GB2157170B (en) 1988-01-20
AU4028785A (en) 1985-09-26
FR2561524A1 (fr) 1985-09-27
HK73090A (en) 1990-09-21
FI82187B (fi) 1990-10-31
SG46890G (en) 1990-08-17

Similar Documents

Publication Publication Date Title
AT394310B (de) Verfahren zur herstellung lagerstabiler, schnellzerfallender pharmazeutischer wirkstoff-presslinge
EP0068191B2 (de) Orale Dipyridamolformen
AT392901B (de) Verfahren zur herstellung einer granulaeren form mit verzoegerter freisetzung von pharmazeutisch wirksamen substanzen
EP0108898B1 (de) Neue orale Mopidamolformen
EP0173210B1 (de) Pellet-Zubereitung
EP0052076B1 (de) Schnellzerfallende Arzneimittel-Presslinge
DE69802543T3 (de) Verbesserte multipartikel-tablette mit schnellauflösbarkeit
DE69434479T2 (de) Tramadolhaltiges Arzneimittel mit gesteuerter Wirkstoffabgabe
EP0032562B1 (de) Neue Dipyridamol-Retardformen und Verfahren zu ihrer Herstellung
EP0607467B1 (de) S(+)-Ibuprofen enthaltende Arzneimittel
EP0052075A1 (de) Körnige Arzneimittel-Retardform
LU81503A1 (de) Arzneimittel-retardform mit unloeslichen poroesen diffusioshuellen
DE29824938U1 (de) Pharmazeutische Zubereitung, die Clodronat als Wirkstoff und silifizierte mikrokristalline Cellulose als Exzipienten umfasst
DE2224534B2 (de) Pharmazeutisches praeparat mit langsamer wirkstoffabgabe
DE3915150A1 (de) Lang-wirkende diclofenac-natrium-praeparation
WO1987005511A1 (en) Nifedipine combination preparation
EP0250648B1 (de) Pharmazeutisches Präparat zur verzögerten Freigabe von Ibuprofen
DE10003757A1 (de) Ibuprofen-Wirkstoffzubereitung
DE4021678C2 (de) Verfahren zur Herstellung klein dimensionierter Formkörper mit hohem Etofibrat-Gehalt und kontrollierter Wirkstoff-Freisetzung, deren Verwendung und daraus bestehende oral verabreichbare Applikationsformen
DE69816124T2 (de) Pharmazeutische zusammensetzungen enthaltend zafirlukast
DE4230563A1 (de) Hochdosierte Kompaktgranulate und daraus hergestellte Tabletten
DE2315006A1 (de) Pankreasenzympraeparat
DE19629032A1 (de) Ephedringranulat mit hohem Wirkstoffgehalt

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8139 Disposal/non-payment of the annual fee